As pharmaceutical and biotech firms race to develop Covid-19 vaccines, how can we ensure that we do not sacrifice security for velocity? Meg Tirrel
As pharmaceutical and biotech firms race to develop Covid-19 vaccines, how can we ensure that we do not sacrifice security for velocity? Meg Tirrell talks to vaccine knowledgeable Dr. Paul Offit on “Wholesome Returns: The Path Ahead”.
For extra unique insights from our reporters and audio system, join for our Wholesome Returns publication to get the most recent delivered straight to your inbox weekly. And for a entrance row seat at CNBC Occasions, you’ll be able to hear instantly from the visionary executives, innovators, leaders and influencers taking the stage in “The Keynote Podcast.” Pay attention now, nevertheless you get your podcasts.